Chromatin proteins have expanded the mammalian synthetic biology toolbox by enabling control of active and silenced states at endogenous genes. Others have reported synthetic proteins that bind DNA and regulate genes by altering chromatin marks, such as histone modifications. Previously we reported the first synthetic transcriptional activator, the "Polycombbased transcription factor" (PcTF), that reads histone modifications through a proteinprotein interaction between the PCD motif and trimethylated lysine 27 of histone H3 (H3K27me3). Here, we describe the genomewide behavior of PcTF. Transcriptome and chromatin profiling revealed PcTFsensitive promoter regions marked by proximal PcTF and distal H3K27me3 binding. These results illuminate a mechanism in which PcTF interactions bridge epigenetic marks with the transcription initiation complex. In three cancerderived human cell lines tested here, many PcTFsensitive genes encode developmental regulators and tumor suppressors. Thus, PcTF represents a powerful new fusionproteinbased method for cancer research and treatment where silencing marks are translated into direct gene activation.
Introduction
Proteins from the gene regulatory complex known as chromatin mediate stable, epigenetic expression states that persist over multiple cell divisions in metazoan tissues. Harnessing the potent generegulating functions of chromatin proteins has become a highpriority for cancer therapy and tissue engineering. The "histone code" model of chromatin function 1, 2 has strongly influenced work in epigenetic engineering and drug development 3, 4 . According to this model, biochemical marks are written onto DNAbound histone proteins and these marks are read when effector proteins physically interact with the modified histones. Then the effector proteins enhance or inhibit transcription initiation. Much of our current understanding about chromatinmediated gene regulation comes from deconstructive methods such as genetic mutations and RNA interference (for examples see 5, 6, 7 ) . Constructive approaches, where synthetic systems are built from chromatin components, are gaining recognition as an important and powerful research method 8, 9 as well as a powerful application for biomedical engineering.
We constructed a synthetic transcription factor based on the natural effector protein CBX8. In many human cancers, lysine 27 on histone H3 (H3K27) becomes marked by trimethylation at abnormally high levels near tumor suppressor loci. CBX8containing complexes accumulate at H3K27me3 and repress gene transcription 10, 11 . A central step in the Polycomb pathway is the specific interaction between the H3K27me3 mark and a hydrophobic binding pocket within the Polycomb chromodomain (PCD) motif of CBX isoforms 12, 13 . We used this interaction to design a Polycombbased transcription factor (PcTF) that has VP64 (tetrameric VP16) and a visible red fluorescent tag (mCherry) fused to the Cterminus of the 60 amino acid PCD. The Cterminal VP64 domain allows PcTF to stimulate activation at repressed H3K27me3associated genes (Fig. 1a) . In previous work, we demonstrated H3K27me3dependent PcTF activity at a model locus ( UASTkluciferase ). PcTF also activated endogenous silenced loci in an osteosarcoma cell line (U2 OS) 14 . Lowresolution protein mapping experiments at four loci identified two promoter regions that were cooccupied by PcTF and H3K27me3. Further investigation is needed to understand and accurately predict targets of the PcTF transcription activator. Here, we report genomewide analyses that substantially advance our understanding of PcTF function. PcTFstimulated gene activation in three different cancer cell types identified a large cohort of universally upregulated genes with a signature H3K27me3 enrichment profile. PcTF is enriched at transcription start sites within the nucleosomefree region of promoters and this profile depends upon the methylhistonebinding PCD domain. We present a model where PcTF bridges distal H3K27me3 with endogenous transcription factors near the transcription start site. These findings provide significant progress towards predicting targets of PcTF based on distributions of epigenetic marks.
RESULTS

Common Polycombsilenced loci are activated in PcTFexpressing cells.
We measured PcTFmediated activation of known Polycomb targets in three different cell lines, osteosarcoma (U2 OS), neuroblastoma (SKNSH), and leukemia (K562). We selected a panel of 13 genes for which Polycombmediated silencing is supported by genetic and pharmacologic disruption studies 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25 and protein mapping studies 26, 27, 28, 29 in human cancers and stem cells: ATF3 , CADM1 , CASZ1 , CDH1 , CLU , HK2 , HOXA6 , HOXB4 , IRF8 , LAMB3 , RUNX3 , TRIM22 , and WT1 . We transfected U2OS, SKNSH, and K562 cells with a PcTFexpressing plasmid ( Fig. 1a ) via Lipofectamine LTX. We used quantitative reverse transcription PCR (qRTPCR) to measure mRNA from mocktransfected (vehicle only) and plasmidtransfected cells ( Fig. 1b ). Primers and dyeconjugated hydrolysis probes are described in Table S1 . In all three cell lines, over half of the genes were activated twofold or higher compared to mocktransfected controls. Upregulation persisted for several genes as PcTF transcript levels decreased over time. Three of the Polycomb target genes were upregulated in all three cell types: ATF3 , CASZ1 , and IRF8 .
We used data from chromatin immunoprecipitation followed by deep sequencing (ChIPseq) to detect H3K27me3 enrichment at Polycomb target genes. In U2 OS, ChIP was performed as previously described using an antibody against H3K27me3 14 . DNA was purified from the immunoprecipitated chromatin, analyzed by next generation deep sequencing, and reads were aligned to the hg19 human genome consensus (Feb. 2009 GRCh37). Regions of enrichment compared to nonimmunoprecipitated bulk chromatin (input) were calculated using the Hotspot algorithm 30 . We used shared and public data to determine H3K27me3 enrichment in SKNSH and K562 cells. ATF3 , CASZ1 , and IRF8 are marked by H3K27me3 ( Fig. S1 ) and become upregulated upon PcTF expression in all three cell types tested here.
HOXA6 , HK2 , and TRIM22 are enriched for H3K27me3 in one or two cell types, and only become upregulated when H3K27me3 is present (Fig. S1 ). These results are consistent with a mechanism where PcTF accumulates at H3K27me3 sites and induces gene transcription. 
PcTF stimulates expression of a large subset of H3K27me3marked genes in U2 OS, SKNSH, and K562 cells.
Wholetranscriptome analysis confirmed upregulation of the known Polycomb targets and revealed a larger subset of commonly upregulated genes. We performed next generation deep sequencing of total RNA (RNAseq) from mock transfected (control) and PcTFexpressing cells (+PcTF) up to 96 hours posttransfection. Wholetranscriptome analyses of U2 OS, SKNSH, and K562 corroborated the qRTPCR results for 9 of the 13 known Polycomb targets:
ATF3 , CASZ1 , CLU , HK2 , HOXA6 , HOXB4 , IRF8 , LAMB3 , and TRIM22 . Comparison of fragments per kilobase of gene model per million mapped reads (FPKM) for control versus +PcTF samples showed that 10.3 23.9% of 23,245 annotated Refseq genes became upregulated 2fold or higher ( Fig. 2a ). This result is consistent with a mechanism where PcTF accumulates at silenced, H3K27me3enriched loci and activates transcription through its Cterminal VP64 domain. We also observed downregulation (foldchange ≤ 2.0) at 6.2 9.3% of the genes in the three cell lines we tested. Repression is inconsistent with the transcriptional activation function of VP64. In some cases, PcTF might disrupt proper gene expression by placing VP64 in a suboptimal position relative to the promoter 31, 32 .
We looked for an epigenetic signature of PcTFsensitive genes by mapping enrichment of H3K27me3 near transcription start sites (TSS's). Overall, H3K27me3 enrichment was depleted near transcription start sites at silenced and active genes, indicated by a sharp valley at position zero in stratified TSSplots (Fig. 2b ). This profile has been observed in other reports; similar plots show a valley in the TSS profile at the nucleosomefree region (NFR) of promoters in mammalian cells 33, 34 . Genes with lower basal expression levels, prior to PcTF expression, show the highest levels of H3K27me3 enrichment which is consistent with the role of H3K27me3 in gene silencing. Genes that became upregulated in response to PcTF expression showed the highest H3K27me3 levels compared to nonresponsive and downregulated genes in K562 cells. This result provides evidence of a mechanism where PcTF accumulates at methylhistone marks through the Nterminal PCD and activates silenced genes through the Cterminal VP64 domain. In SKNSH and U2 OS however, upregulated genes showed the same or lower H3K27me3 levels as nonresponsive genes. Therefore, PcTFsensitivity may not be strictly determined by methylation signal levels that were determined by ChIP analysis.
We hypothesized that a specific H3K27me3 distribution pattern around the TSS determines which genes are activated by PcTF. We identified a subset of 263 commonly upregulated genes ( Fig. 2c ) in order to exclude genes that behave in a celltypespecific manner. In U2 OS and SKNSH, we observed depletion of H3K27me3 at the TSS, surrounded by signal peaks at intervals of roughly 1 kb. ChIP hotspot densities around the TSS were highest for genes with low basal expression levels (0.001 1.0 FPKM) ( Fig. 2c ). The highest peaks for K562 were observed immediately downstream of the TSS and 3 kb upstream ( Fig. 2c ). Altogether, these data suggest that PcTFmediated activation of silenced genes may rely on H3K27me3 enrichment at positions distal to the TSS. 
ChIPseq analyses show PCDdependent enrichment of PcTF near transcription start sites
In order to further investigate the mechanism of PcTFmediated gene regulation, we used ChIPseq to compare the distribution of PcTF and H3K27me3 throughout the genome and at TSS regions. We performed ChIPseq on chromatin from an isogenic PcTFexpressing U2 OS cell line. The cell line "U2OSPcTF" carries a chromosomallyintegrated, TetRrepressed gene that expresses myctagged PcTF when the cells are treated with doxycycline ( Fig. 3a) , as described previously 14 . We used this system for ChIPseq instead of transiently transfected cells in order to eliminate negative background from PcTFminus cells. ChIP was performed as previously described using either an antibody against the PcTF Nterminal myc tag for U2OSPcTF cells or antiH3K27me3 for the Flpin TREx parental line 14 . ChIPseq analysis of a truncated version of PcTF that lacks the PCD domain (ΔTF) showed little overlap with PcTF and H3K27me3 (Fig. S2 ), which indicated that PcTF and H3K27me3 distributions were not due to random crosslinking. We analyzed the distributions of PcTF and H3K27me3 ChIP at different genomic features and observed the greatest enrichment over background for intergenic regions (Fig. 3b ). PcTF, but not H3K27me3, showed signal enrichment at promoters. These results indicate that PcTF and H3K27me3 cooccupy noncoding regions, and that PcTF is frequently enriched at promoter sites.
We inspected promoter regions more closely by identifying PcTF and H3K27me3 enriched regions surrounding TSS's. We identified 5535 regions that were marked with PcTF or H3K27me3 or both. A TSS plot showed a peak of PcTF enrichment at the TSS over a 2 kb interval ( Fig. 3c ). Randomly crosslinked ΔTF did not show the same enrichment profile, therefore mCherrytagged VP64 alone does not account for the enrichment pattern of PcTF. In contrast to PcTF, H3K27me3 was depleted at the TSS. The subset of 316 regions in which we detected both PcTF and H3K27me3 showed a similar but shorter PcTF enrichment peak. H3K27me3 signal was depleted near the TSS, with dispersed peaks of H3K27me3 further from the TSS. The profiling data suggest that at cooccupied regions, PcTF enrichment appears at and adjacent to the TSS, while H3K27me3 is farther away either upstream or downstream. Overall, these results suggest that PcTF accumulates near the TSS, and that this accumulation depends upon interaction with distal H3K27me3 through the Nterminal PCD peptide. 
Upregulated genes are marked by H3K27me3 upstream and PcTF near the TSS in U2OSPcTF cells
Upregulation of PcTFsensitive genes corresponds with H3K27me3 enrichment at roughly 1 2 kb upstream of the transcription start site in regions where we also detected PcTF enrichment near the TSS. To identify upregulated genes, we compared RNAseq FPKM values of 23,244 genes for U2OSPcTF cells that were untreated or treated with doxycycline (dox) to induce PcTF expression. Known Polycomb targets LAMB3 , IRF8 , CASZ1 , RUNX3 , HOXB4 , and CDH1 were upregulated 2fold or higher. For transcript levels that changed at least twofold in either direction, the predominant response was an increase in expression of genes that had a low initial expression state in control cells. FPKM values of silenced genes are typically lower than 1.0 35 . The frequency of upregulated genes within the nonexpressing FPKM range of 10 4 10 0 was 23%, whereas only 3% of active genes were upregulated (Fig. 4a ).
Stratified TSS plots showed that PcTF was frequently enriched immediately downstream of the TSS at upregulated genes (Fig. 4b) . H3K27me3 was depleted near the TSS and showed peaks of enrichment 1 kb, 2 kb and 4 kp upstream. Median distances of the nearest H3K27me3 signal were 2545.5 bp for 2 to 8fold upregulated genes and 1365 bp for genes that were upregulated 8fold or higher (Fig. 4c ). We observed a significant (p < 0.05) increase in expression across two independent experimental replicates for five of the upregulated genes: PTRF , CDKRAP3 , PPIA , ELFN2 , POR , and CARD10 (Fig. 4d ). For genes that showed no change or were downregulated, median distances ranged from 588.5 to 93.5 bp. Positioning of H3K27me3 very close to the TSS at nonresponsive and downregulated genes might interfere with VP64driven gene activation, or cause VP64 to recruit transcription factors to a site that is not optimal for proper transcription. These data indicate that a distal H3K27me3 mark positions PcTF at an optimal position to allow the VP64 activation domain to stimulate gene transcription at target promoters. 
H3K27me3 enrichment occurs near enhancers at PcTFsensitive loci
Sites that are distal from the TSS are known as enhancers, which are often bound by regulatory proteins that interact with transcription factors at the TSS and stimulate or repress gene expression. We hypothesized that PcTF stimulates expression at genes where a nearby enhancer is enriched for H3K27me3. Investigation of the chromosomal positions of PcTFsensitive genes, enhancers, and H3K27me3 revealed that histone methylation at upstream enhancers corresponds with PcTFmediated gene activation. Enhancer regions were identified from the 15 classes of human chromatin states from the ENCODE project for 9 different human cell types 36 , including K562. Enhancer coordinates were based on class 4 (strong enhancer) and class 5 (medium enhancer) hg19 annotations from the public K562 cell data. We identified the closest enhancer element near 23,245 TSS's at both the upstream and downstream position and calculated median distances to the nearest H3K27me3 signal (Fig.  5a ). Genes with FPKM values of zero in both control and treated cells were excluded from the calculations. We observed that H3K27me3 ChIP signals occur close to upstream enhancer midpoints at higher frequencies near upregulated genes. U2 OS cells showed the strongest correlation (Pearson R 2 = 0.79) between H3K27me3proximal, upstream, class 4 enhancers and foldchange expression in response to PcTF.
Close inspection of gene regions further supported the significance of H3K27me3 positioning at enhancers near PcTFsensitive genes. At CASZ1 , one of the known Polycomb targets, the upstream enhancer regions were positioned near H3K27me3 enrichment signals in all three cell types. ELFN2 , a gene that became upregulated after PcTF expression in all three cell types, also showed H3K27me3 proximity to upstream enhancers. At AMHR2 , H3K27me3 ChIP hotspots appear about 1 kb from the TSS, between the nearest enhancer and the nearest PcTF ChIP signal in U2 OS and K562 (Fig. 5b) . AMHR2 was upregulated by PcTF in U2 OS and K562, but not in SKNSH where we found no H3K27me3 signal within the same region. These results suggest that H3K27me3 at enhancer elements upstream of the TSS contributes to PcTFmediated gene activation. 
DISCUSSION
The work presented here provides new insights into the mechanism of PcTF, a synthetic chromatinbased transcription factor. PcTF couples recognition of a silencingassociated mark with gene activation. PcTF enrichment near TSS sites is similar to the patterns that have been observed for subunits of the transcription initiation complex 33, 37 , suggesting a strong interaction with endogenous transcription factors. The Cterminal domain of PcTF includes VP64 which is composed of four copies of a core acidic transcription activation domain (TAD) from VP16 38 . The TAD is derived from the H1 region of VP16, which has been shown to bind with high affinity (high nanomolar range) to the Mediator complex subunit MED25 39 . The VP16 TAD also interacts with MED17, several members of the Transcription Factor II (TFII) family, and the TATA promoter motifbinding protein TBP (reviewed in 40, 41 ). In contrast, the Cterminal PCD has relatively low affinity (high micromolar range) for H3K27me3 42 . PCDH3K27me3 binding may be weak in vivo , but it is still necessary for PcTF function 14 and for TSSproximal enrichment (Fig.  3C ). Enrichment of PcTF in regions that are near to but do not overlap with H3K27me3 was observed in our previous ChIPPCR studies 14 . This offset of PcTF ChIP signals from H3K27me3 sites suggests that PcTF engages with H3K27me3 and then becomes trapped near the TSS through interactions with the transcription initiation proteins in crosslinked chromatin. The data provide strong evidence for a mechanism where PcTF bridges distal histone methylation marks with PolIIassociated transcription factors at the nucleosomefree TSS (Fig. 6 ). RNAseq results for genes that do not appear to be direct targets of PcTFmediated activation provide additional insights into gene regulation. Many of the genes we analyzed in the RNAseq experiments do not change more than twofold or become downregulated after PcTF expression. In these cases, suboptimal positioning of the VP64 domain of PcTF relative to the promoter might neutralize its activity or lead to reduced expression below basal levels 31, 32 . We observed several genes that became up or downregulated, but lacked a PcTF signal within 10 kb of the TSS. Regulation of these genes could be mediated by transcription regulators that are direct targets of PcTF. For example upregulated, PcTFmarked genes including ATF3 and CASZ1 encode broadlyacting transcriptional regulators that control multiple targets 43, 44 .
Our work has significant implications for medicine. Currently, epigenetic engineering relies largely on smallmolecule inhibitors that are intended to erase cancerassociated epigenetic silencing and indirectly activate therapeutic genes. These drugs have major shortcomings such as incomplete erasure of cancerassociated methylhistone marks and DNA damage. Here, we used a synthetic chromatin protein, PcTF, to convert the methylhistone signal into direct activation of therapeutic genes instead of inhibitors to erase cancerassociated marks. Genes that were consistently upregulated by PcTF in all three cell lines we tested have therapeutic potential. Work by others has shown that induced upregulation of the transcription factor ATF3 antagonizes cancer cell growth and invasion in certain tissues, such as ovarian (OVAC) 45 and esophageal (ESCC) 46 . Overexpression of the CASZ1 transcription regulator inhibits proliferation of neuroblastoma (SHSY5Y) 47 . Additional work to determine the specificity of PcTF in cancer versus healthy cells and to enhance efficient synthetic protein delivery will bring this promising new technology closer to translation.
ONLINE METHODS
DNA constructs
The doxycyclineinducible PcTFexpressing plasmid has been described previously 14 . The plasmid is constitutively expressed in the absence of a TetR protein (in cell lines U2 OS, SKNSH, and K562). The full annotated sequence of "hPCDTF" is available online at Benchling Hayneslab: Synthetic Chromatin Actuators (https://benchling.com/hayneslab/f/S0I0WLoRFKsyntheticchromatinactuators/seqfSG2GUbr hpcdtf/).
Chromatin Immunoprecipitation followed by deep sequencing (ChIPseq)
Chromatin immunoprecipitation was performed on U2 OS FlpIn TRex cells, which carry a chromosomal insert of a TetRrepressible PcTF gene as previously described 14 
Cell culture and transfection
Complete growth media contained 10% tetracyclinefree fetal bovine serum and 1% penicillin and streptomycin (pen/strep). U2 OS and U2OSPcTF cells were cultured in McCoy's 5A. K562, and SKNSH cells were cultured in IMDM, or EMEM, respectively. Cells were grown at 37 °C in a humidified CO 2 incubator. U2OSPcTF stable cell lines were generated by previously published work 14 . PcTFexpressing U2 OS, K562, and SKNSH cells were generated by transfecting 5x10 5 cells in 6well plates with DNA/Lipofectamine complexes: 2 μg of plasmid DNA, 7.5 μl of Lipofectamine LTX (Invitrogen), 2.5 PLUS reagent, 570 µl OptiMEM. Transfected cells were grown in pen/strepfree growth medium for 18 hrs. The transfection medium was replaced with fresh, pen/strepsupplemented medium and cells were grown for up to 48 hrs. (K562) or up to 96 hrs. (U2 OS and SKNSH).
Quantitative Reverse Transcription PCR (qRTPCR)
Total messenger RNA was extracted from ~90% confluent cells (~12x10 6 ). Adherent cells (U2OS and SKNSH) were lysed directly in culture plates with 500 μl TRIzol. Suspended cells (K562) were collected into tubes, pelleted by centrifugation at 1000 xg for 3 min. at room temperature, separated from the supernatant, and lysed in 500 μl TRIzol. TRIzol cell lysates were extracted with 100 μl chloroform and centrifuged at 12,000 xg for 15 min. at 4 °C. RNA was columnpurified from the aqueous phase (Qiagen RNeasy Mini kit 74104). SuperScript III (Invitrogen) was used to generate cDNA from 2.0 μg of RNA. Realtime quantitative PCR reactions (15 μl each) contained 1x LightCycler 480 Probes Master Mix (Roche), 2.25 pmol of primers (see Supplemental Table 1 for sequences), and 2 µl of a 1:10 cDNA dilution (1:1000 dilution for GAPDH and mCh). Crossing point (C p ) values, the first peak of the second derivative of fluorescence over cycle number, were calculated by the Roche LightCycler 480 software. For each experiment (one cell type, one target gene, all time points) C p values were normalized to the highest value. "Expression level" was calculated as delta C p , 2^[C p GAPDH C p experimental gene], for PcTFexpressing cells. Foldchange was determined as Expression level divided by delta C p for nonPcTF control cells.
RNAseq
RNAseq was performed using two replicates per experimental condition. Total RNA was prepared as described for qRTPCR. 50 ng of total RNA was used to prepare cDNA via single primer isothermal amplification using the Ovation RNASeq System (Nugen 7102A01) and automated on the Apollo 324 liquid handler (Wafergen). cDNA was sheared to approximately 300 bp fragments using the Covaris M220 ultrasonicator. Libraries were generated using Kapa Biosystem's library preparation kit (KK8201). In separate reactions, fragments from each replicate sample were endrepaired, Atailed, and ligated to index and adapter fragments (Bioo, 520999). The adapterligated molecules were cleaned using AMPure beads (Agencourt Bioscience/Beckman Coulter, A63883), and amplified with Kapa's HIFI enzyme. The library was analyzed on an Agilent Bioanalyzer, and quantified by qPCR (KAPA Library Quantification Kit, KK4835) before multiplex pooling and sequencing on a Hiseq 2000 platform (Illumina) at the ASU CLAS Genomics Core facility.
Bioinformatics analysis
ChIPseq alignments were carried out using the Bowtie2 algorithm 47 with the hg19 reference genome (Feb. 2009 GRCh37). Enrichments normalized to input were calculated using the Hotspot algorithm (distribution version 4) 48 . ChIPseq data for SKNSH was provided by B. Bernstein and K562 data was retrieved from the UCSC Genome Browser website 49 . Galaxy ( http://www.usegalaxy.org ) 50 was used to identify overlaps with a minimum of 1 bp between gene intervals and ChIPseq enrichment intervals. ChIPseq profiling across genes and intergenic regions was performed using the Cistrome platform 51 . RNAseq alignments were carried out with demultiplexed 50bp singleend reads and the hg19 transcriptome using Bowtie 2. Transcript abundance and differential expression were calculated using Tophat and Cuffdiff 52 within the Galaxy online platform using the Homo sapiens UCSC hg19 gene transfer format (gtf) file from Illumina iGenomes. Outdated genes were identified by crossreferencing gene symbols with the NCBI database. Outdated genes and duplicate transcription start sites were removed from the Cuffdiff output in Excel, resulting in 23,245 genes. Analysis of distances between features (TSS's, ChIP signals, and enhancers) was performed and all graphs and charts were generated in Excel.
